Pharmacogenetics in the Rheumatic Diseases

被引：0
|
作者：
Cronstein, Bruce N. [1 ]
机构：
[1] NYU, Sch Med, Med Pathol & Pharmacol, New York, NY 10016 USA
来源：
BULLETIN OF THE HOSPITAL FOR JOINT DISEASES | 2006年 / 64卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
Designing a therapeutic plan that involves the least risk of toxicity and the greatest chance of success is the goal of the modern physician. To better achieve this goal an understanding of the genetic basis for drug efficacy and toxicity is essential. Here we review the available information on the pharmacogenetics of drugs commonly used to treat rheumatic diseases in the hope that the application of this information to the patient will contribute to more effective and safer therapies for rheumatoid arthritis, systemic lupus erythematosus, and other inflammatory diseases.
引用
收藏
页码：16 / 19
页数：4
相关论文
共 50 条
12345